The dawn of a new era of targeted lipid-lowering therapies.
Sign Up to like & getrecommendations! Published in 2022 at "European heart journal"
DOI: 10.1093/eurheartj/ehab841
Abstract: Lipid risk factors for cardiovascular disease depend in part on lifestyle, but optimum control of lipids often demands additional measures. Low-density lipoprotein (LDL) doubtless contributes causally to atherosclerosis. Recent human genetic findings have substantiated a… read more here.
Keywords: dawn new; new era; targeted lipid; lipid lowering ... See more keywords